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Abstract
Background: This study aimed to evaluate the efficacy and safety of Scepter dual-lumen balloon catheter for
transarterial Onyx embolization of dural arteriovenous fistula (DAVF).
Methods: Transarterial Onyx embolization using a Scepter dual-lumen balloon catheter (Scepter-assisted Onyx
embolization) for DAVF was attempted in a total of 35 patients (mean age, 52.5 years; M:F = 24:11) between
October 2012 and December 2018. The results of Scepter-assisted Onyx embolization were evaluated with respect
to total procedural and Onyx injection times, the types and number of feeders requiring embolization, angiographic
and clinical outcomes, and treatment-related complications.
Results: Initial presentations were non-hemorrhagic neurological deficits in 10, intracranial hemorrhage in 8, seizure
in 7, headache in 7, and intractable tinnitus in 3. All DAVF were aggressive type (Borden type 2, 14.3 %; type 3,
85.7 %). Scepter-assisted Onyx embolization resulted in immediately complete occlusion in 33 patients (94.3 %) and
near complete occlusion in 2 patients. Middle meningeal artery (51.4 %) was the most commonly used for Scepter-
assisted technique, followed by occipital artery (42.9 %), ascending pharyngeal artery (2.9 %) and superficial
temporal artery (2.9 %). There was no difference in complete occlusion rate between middle meningeal artery and
the other arteries (94.4 % versus 94.1 %). The median number of total feeders embolized was 1 (range, 1–3). The
median total procedural time was 45 minutes (range, 21 minutes – 127 minutes) and the median Onyx injection
time was 11 minutes (range, 3 minutes – 25 minutes). All patients recovered completely (n = 31) or partially (n = 4)
from presenting symptoms. Treatment-related complications occurred in 2 patients, of whom one had a permanent
morbidity (2.8 %, ipsilateral facial nerve palsy). No patient showed a recurrence on follow-up imaging (median, 15
months; range, 3–56 months).
Conclusions: Scepter-assisted transarterial Onyx embolization showed a very high complete occlusion rate with a
low morbidity and no recurrence in aggressive type DAVF. Scepter dual-lumen balloon catheter seems to be a
useful tool for transarterial Onyx embolization of DAVF.
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Background
Multi-therapeutic options such as stereotactic radiosur-
gery, microsurgery and endovascular treatment are used
for treatment of DAVF [1, 2]. The Onyx Liquid Embolic
agent (eV3 Endovascular, Plymouth, Minnesota) facilitates
controlled penetration into the fistula, thereby improving
the cure rate of endovascular mean. Therefore, Onyx has
been a popular agent for AVF and AVM. Effective pene-
tration requires an antegrade flow of Onyx from the feed-
ing artery to the fistula site. With conventional
microcatheter-based techniques, an initial proximal plug
is often necessary, unless the tip of a microcatheter could
be positioned completely wedged at the target feeding ar-
tery. That is also true with a detachable microcatheter.
Subsequently, conventional technique takes a considerable
amount of time to form a firm plug in order to facilitate
effective penetration and to avoid reflux of Onyx. Re-
cently, several small case series have documented that use
of a dual-lumen balloon catheter (Scepter, Microvention,
Tustin, California) enables more effective penetration and
requires shorter injection time than the conventional
microcatheter technique [3, 4].
The objective of this study was to evaluate the efficacy
and safety of Scepter dual-lumen balloon catheter for
transarterial Onyx embolization of dAVF.
Methods
The Institutional Review Boards at all participating hos-
pitals involved approved this retrospective study and
waived the patient informed consent for study inclusion.
Written informed consent for embolization was obtained
from the patient or a legal representative before
treatment.
All patients in whom the Scepter dual-lumen balloon
catheter was attempted as a primary delivery tool for
Onyx embolization for aggressive-type DAVF were iden-
tified from a prospectively maintained neurointerven-
tional database in 3 hospitals between October 2012 and
December 2018. Aggressive-type was defined as DAVF
with cortical reflux (Borden type 2) or a directly draining
cortical vein (Borden type 3).
Transarterial Onyx embolization
All procedures were performed under general anesthesia.
If it had been one of the feeders of DAVF, middle men-
ingeal artery was preferentially selected for Onyx
embolization. For overcoming the difficulty, if any, in
navigation of the Scepter balloon catheter, the following
techniques were used. (1) The tip of scepter balloon
catheter was almost always steam-shaped for improving
navigability. (2) The distal access catheter has always
been used combined with a Shuttle 6F sheath for more
supporting the Scepter balloon catheter. (3) If needed,
exchange technique was employed for placing the
scepter balloon catheter into the target point of the feed-
ing artery using a microcatheter with inner lumen of
0.0165-inch and a 300-cm length, 0.014-inch exchange-
able microwire (Transend, Stryker). In detail of exchange
technique, a 0.0165-inch microcatheter was navigated to
the target point of the feeding artery. An exchangeable
wire was placed followed and the microcatheter was re-
moved. Finally, Scepter balloon catheter was advanced
over the exchange wire. In addition, vasodilator (Nimo-
dipine, 0.3–0.5 mg) was infused into the feeding artery
before the navigation of Scepter catheter to prevent
vasospasm. The essential prerequisite of the target pos-
ition of the Scepter balloon catheter within the feeding
artery is that there is no functioning arterial branch aris-
ing between the point and the fistula.
Main Outcomes
We evaluated the results of Scepter-assisted transarterial
Onyx embolization with respect to treatment-related
complications, angiographic outcome, total procedural
time, Onyx injection time, and number of feeders
needed for completion of embolization. Angiographic
outcomes were classified as complete occlusion, near
complete occlusion, or incomplete occlusion. Complete
occlusion of d-DAVF was defined as no visualization of
the isolated sinus or shunted cortical vein in the delayed
venous phase on the completion angiogram. Near
complete occlusion was defined as delayed visualization
of the isolated sinus or shunted vein on the venous
phase, with marked stasis of contrast material (≥ 2 sec-
onds). Incomplete occlusion was defined as visualization
of the isolated sinus or shunted vein on the arterial
phase of the completion angiogram, with stasis of con-
trast material < 2 seconds.
Routine follow-up imaging was scheduled at 6 months
with magnetic resonance angiography (MRA) or digital
subtraction angiogram (DSA) and 24 months after the
embolization. MRA was used for first follow-up modality
in 20 cases and DSA was in 15 cases. MRA was routinely
used for second follow-up, unless patient’s presenting
symptoms were not improved or aggravated. If MRA
source images show any high signal on the lesion in
cases that MRA was used for follow-up modality, or pa-
tient’s presenting symptoms were not improved or ag-
gravated, DSA was performed for confirmation.
Angiographic and follow-up imaging outcomes were
assessed by 2 independent raters who did not partici-
pated in the treatment. Inter-rater agreements were al-
most perfect for both immediate and follow results
(kappa value = 0.97 and 0.93, respectively).
Statistical analysis
Since this study evaluated the efficacy and safety of
Scepter balloon catheter as a primary tool for Onyx
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embolization of DAVF without comparison with the
other tools or methods, only descriptive statistics are
presented. All data are presented as a mean and range
for continuous variables and as a number and percent-
age for categorical variables.
Results
Of the 53 patients who underwent transarterial
embolization for cranial dAVF between September 2012
and December 2018. The Scepter balloon catheter was
attempted to navigate to the target point (distal to the
origin of potentially dangerous branch) of the feeding ar-
tery in 36 patients. Of them, the navigation of Scepter
balloon catheter failed in 1 patient and Scepter balloon
catheter was used as a primary delivery tool for Onyx
delivery for DAVF in a total of 35 patients (97.2 %; mean
age, 52.5 years; M:F = 24:11). Baseline clinical and angio-
graphic characteristics of the patients are summarized in
Table 1. Initial presentations were non-hemorrhagic
neurological deficits in 10, intracranial hemorrhage in 8,
seizure in 7, headache in 7, and intractable tinnitus in 3.
All DAVF were aggressive type; Borden type 2, 5
(14.3 %) and type 3, 30 (85.7 %), respectively.
Procedural details, clinical and angiographic outcomes
are summarized in Table 2.
Scepter-assisted Onyx embolization resulted in imme-
diately complete occlusion in 33 patients and near
complete occlusion in 2 patients. Exchange technique
was applied with a 0.014-inch thickness and 300-cm
length wire (Transcend exchangeable wire, Stryker or
Grandslam, Abbort, ) for navigation of Scepter dual-
lumen balloon catheter to a target position in a very tor-
tuous feeder artery in 5 patients (14.3 %).(Fig. 1) Planned
adjunctive embolization with N-butyl cyanoacrylate was
conducted in 2 patients (5.7 %) with multiple feeders im-
mediately before Scepter-assisted Onyx embolization.(-
Fig. 2) The median number of total feeders embolized
was 1 (range, 1–3). Middle meningeal artery (51.4 %)
was the most commonly used for Scepter-assisted tech-
nique, followed by occipital artery (42.9 %), ascending
pharyngeal artery (2.9 %) and superficial temporal artery
(2.9 %). There was no difference in complete occlusion
rate between middle meningeal artery and the other ar-
teries (94.4 % versus 94.1 %). The median total proced-
ural time was 45 minutes (range, 21 minutes – 127
minutes) minutes and the median Onyx injection time
was 11 minutes (range, 3 minutes – 25 minutes). Com-
paring the Onyx injection time between middle menin-
geal artery and occipital artery, it was significantly
shorter at the middle meningeal artery (9 ± 4 minutes)
than at the occipital artery (13 ± 9 minutes). (Table 2)
All patients recovered completely (n = 31) or partially
(n = 4) from presenting symptoms. Treatment-related
Table 1 Baseline clinical and angiographic characteristics
Age, mean (range), years 52.5 (18–78)
Male, n (%) 24 (68.6)
Presentation, n (%)
Non-hemorrhagic neurological deficits 10 (28.6)
Intracranial hemorrhage 8 (22.9)
Seizure 7 (20.0)
Intractable Headache 7 (20.0)
Intractable tinnitus 3 (8.5)
Location, n (%)
Transverse-sigmoid sinus 13 (37.1)
Juxta-sinus lacuna (bridging vein between cortical veins
and sinus)
13 (37.1)
Superior petrosal sinus 5 (14.3)
Torcula 3 (8.6)
Sphenoparietal sinus 1 (2.8)
Type, n (%)
Borden type 2 5 (14.3)
Borden type 3 30 (85.7)
Table 2 Procedural details, clinical and angiographic outcomes
of Scepter-assisted Onyx embolization
Planned adjunctive NBCA embolization of another
feeder(s) immediately before Onyx embolization, n
(%)
2 (5.7)
Total number of feeders embolized, median (range) 1 (1–3)
Feeding artery selected for Scepter-assisted technique
Middle meningeal artery, n (%) 18 (51.4)
Occipital artery, n (%) 15 (42.9)
Superficial temporal artery, n (%) 1 (2.9)
Ascending pharyngeal artery, n (%) 1 (2.9)
Total procedural time, mean ± SD (range), minutes 43 ± 28 (21–127)
Onyx injection time, mean ± SD (range), minutes
Injection time through middle meningeal artery (n =
18)
Injection time through occipital artery (n = 15)
11 ± 7 (3–25)
9 ± 4 (3–17)*
13 ± 9 (8–25)*
Immediate angiographic results, n (%)
Complete occlusion 33 (94.3)
Near complete occlusion 2 (5.7)
Treatment-related permanent morbidity, n (%) 1 (2.8)
Clinical follow-up duration, median (range), months 25 (3–78)
Clinical follow-up results, n (%)
Complete resolution of presenting symptoms 30 (85.7)
Partial improvement from presenting symptoms 5 (14.3)
Imaging follow-up duration, median (range), months 15 (3–56)
Imaging follow-up results (n = 33), n (%)
Complete occlusion 32 (97.0)
Near complete occlusion 1 (3.0)
*Significantly different (p < 0.05)
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complications occurred in 2 patients, of whom one had
a permanent morbidity (2.8 %, ipsilateral facial nerve
palsy). One patient presented with intractable right facial
spasm due to neurovascular compression from the
engorged draining vein of the dAVF at right superior pe-
trosal sinus. The patient experienced right facial palsy
after Onyx embolization, likely due to penetration of
Onyx into the petrous branch, which supplies the pet-
rous segment of the facial nerve via artery-to-artery
anastomosis. The other patient experienced a transient
contralateral sensory change but completely recovered
in a week.
No patient showed a recurrence on follow-up imaging
(median, 15 months; range, 3 months – 56 months).
Discussion
The results of this study demonstrated that (1) the navi-
gation of Scepter balloon catheter to the target point
(distal to the potentially dangerous branch) of the feeding
artery was successful in 97.2 % of the attempted cases, (2)
Scepter-assisted transarterial Onyx embolization showed a
very high successful (94.3 % complete and 5.7 % near
complete) occlusion rate with a low permanent morbidity
(2.8 %), (3) Scepter-assisted technique was as effective
using the other feeding arteries as middle meningeal
artery, and finally, (4) the Onyx injection (median, 11 mi-
nutes; range, 3–37 minutes) and total procedural (median
35 minutes; range, 21–127 minutes) times were quite
shorter than those of conventional technique in the litera-
ture, onyx injection time ranged 30minutes from 15 to 60
minutes [5]. Since Scepter dual lumen balloon microcath-
eter was introduced [3], several small case series showed
that it might be a promising Onyx delivery tool for the
treatment of dural AVF. In this study, we evaluated that
Scepter balloon catheter can be used as a primary tool for
Onyx embolization, to our best knowledge, in the largest
population.
Traditionally, transarterial embolization of dAVF has
been associated with a high failure rate and was consid-
ered palliative or adjunctive to transvenous
embolization. In the last 10 years, however, there has
been a paradigm shift toward transarterial embolization
of dAVF. Since its introduction, Onyx has gained wide-
spread popularity as a primary embolic agent for various
vascular lesions. Due to its cohesive property, Onyx can
allow for a more controlled injection and penetration into
the target lesion. As a result, contemporary series have
consistently demonstrated cure rates with transarterial
embolization exceeding 70 % [6]. Nevertheless, to control
the direction of the Onyx toward the target lesion with
Fig. 1 A 49-year-old man presenting with intracranial hemorrhage. a and b Anterior (a) and lateral (b) angiograms show dural arteriovenous
fistula at the left superior petrosal sinus with reflux into contralateral medullary veins. c and d Transparent image (c) of 3D angiogram and thick
slice maximum intensity reconstruction image (d) demonstrate two main feeding arteries, inferolateral trunk (white arrow) and occipital artery
branch (black arrow). Note that inferolateral trunk has very tortuous course and occipital artery branch has trans-osseous course. e A
microcatheter with inner diameter of 0.0165-inch is navigated into the occipital branch with a 0.014-inch wire. Arrowhead indicates the tip of
microcatheter and arrow indicates 5-F intermediate catheter. f A Scepter-C dual lumen balloon catheter is placed using exchange technique with
0.014-inch 300-cm length exchangeable wire. Black arrowhead indicates the tip of Scepter-C and white arrowheads indicate proximal and distal
markers of balloon. g A spot image near the end of the procedure. Dashed arrow indicates inflated balloon. h The final control angiogram at the
common carotid artery reveals complete occlusion of the fistula
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conventional technique, the formation of a proximal plug
around the microcatheter tip should be preceded before
antegrade propagation of Onyx in most cases. This, in
turn, results in increased procedural and fluoroscopy
times. Furthermore, excessive and unwanted reflux of
Onyx into proximal segment of the feeding artery may not
rarely occur, which leads to incomplete occlusion or fail-
ure of embolization. Such a phenomenon is more com-
mon in highly resistant and tortuous artery such as
occipital artery than middle meningeal artery. Therefore,
most investigators recommend middle meningeal artery
as a primary conduit for Onyx delivery [7–9].
Recently, Kim et al. reported a small case series that
compared the results of conventional microcatheter
technique (n = 14) and Scepter-assisted technique (n =
16). That study demonstrated that utilization of Scepter-
assisted technique clearly increased the immediate
complete occlusion rate (86.7 % versus 35.7 %) and de-
creased total procedural time (62 ± 32 minutes versus
171 ± 88 minutes), Onyx injection time (10 ± 6 minutes
versus 49 ± 32 minutes, and number of feeding arteries
(1 versus 2) required for completion of embolization.
The results of the present study also showed similar re-
sults to those of Scepter-assisted technique group, which
can provide additional evidence to the usefulness of
Scepter-assisted technique.
When recommending Scepter balloon catheter as a
primary delivery tool for Onyx embolization, the navig-
ability of the balloon catheter into the target feeding ar-
tery is a major huddle. In this study, for navigation of
the Scepter balloon catheter to a very tortuous feeding
artery, exchange technique was used in 14.3 % and distal
access catheter in addition to shuttle sheath has been
routinely used since its introduction. Subsequently, the
navigation of Scepter balloon catheter was attempted in
approximately two thirds of all cranial dAVF and was
successful in all but one. In fact, the navigation of the
Scepter balloon catheter to the target point of the feed-
ing artery succeeded in all cases after using a distal ac-
cess catheter.
Middle meningeal artery is the most common feeding
artery of cranial dAVF and recommended as a primary
conduit for Onyx delivery in literature [7–10]. However,
middle meningeal artery is not always the feeder artery
of dAVF and furthermore often trivially contributes as a
feeder. Occipital artery is a second most common con-
tributing artery but has usually very tortuous course and
high resistance because it is trans-osteal artery.
Fig. 2 A 60-year-old man presenting with intractable tinnitus and dizziness. a and b Right (a) and left (b) external carotid artery angiograms
reveal dural arteriovenous fistula at the torcula, which shows numerous feeding arteries and reflux to superior sagittal sinus (asterisk). Note that
left transverse sinus is occluded and right transverses-sigmoid sinus shows focal stenosis (arrow). c and d Frontal (c) and lateral (d) spot images
shows the position of Scepter-C dual lumen balloon catheter at the left middle meningeal artery. Note that proximal coil-protected embolizations
were done using the mixture of N-butylacrylate and contrast material two times at the right occipital artery branches. Black arrowhead indicates
the distal marker and white arrowheads indicate proximal and distal balloon markers of Scepter-C. e A spot image during the Onyx injection
through the Scepter-C under roadmap. f and g Non-subtracted (f) and subtracted (g) angiograms reveal complte occlusion of dural
arteriovenous fistula. h Venous phase angiogram after balloon angioplasty for the stenosis show patent torcula (long arrow) and improved
stenosis of right transvers-sigmoid sinus
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Therefore, the cure rate of Onyx embolization with con-
ventional technique is lower using occipital artery than
middle meningeal artery. It has been suggested as a
major cause of transarterial Onyx embolization failure
with conventional technique [10]. In the present study,
middle meningeal artery and occipital artery was se-
lected for Scepter-assisted technique in 51.4 % and
42.9 %, respectively. However, there was no difference in
complete occlusion rate between middle meningeal ar-
tery and the other arteries. It is largely because the firm
inflated balloon of Scepter catheter makes it much easier
to penetrate via a highly resistant occipital artery into
the fistula. On the other hand, the Onyx injection time
was shorter at the middle meningeal artery than at the
occipital artery. It suggests that middle meningeal artery
is better than occipital artery even for Scepter-assisted
Onyx embolization in terms of the injection time if both
arteries are usable.
The complication associated with onyx embolization
include catheter entrapment, cranial nerve damage and
distal propagation of onyx [11–13]. In meta-analysis of
trans arterial onyx embolization for the intracranial
dural fistulas, procedure-related morbidity was 3 % (95 %
CI: 1 %, 5 %; I2, 0 %) [14]. In this study, treatment-
related complications occurred in 2 patients, of whom
one had a permanent morbidity (2.8 %, ipsilateral facial
nerve palsy). There was no arterial rupture due to bal-
loon over-inflation. All treated feeding arteries were ex-
ternal carotid artery branches which have external
elastic lamina and thicker media, compared to intradural
cerebral arteries in which external elastic lamina is ab-
sent. Therefore, the branches of external carotid artery
may be quite endurable in the condition of stretching by
balloon over-inflation. Even if dural arterial rupture hap-
pens, in our opinion, it can be easily controlled by fur-
ther injection of onyx for embolization of the ruptured
artery because any functioning branch do not arise from
the target point of the artery. The final concern is en-
trapment of the balloon catheter. In our experience,
however, although some distance of Onyx reflux oc-
curred around the inflated balloon, deflation of the bal-
loon easily separated the catheter from the Onyx coating
vessel wall and retrieval of the Scepter catheter is very
easy, taking less than 10 seconds in all cases.
Limitation
This study has several limitations inherent to retrospect-
ive analysis. This study did not compare Scepter-assisted
technique with the other technique. However, the preva-
lence of dAVF requiring treatment is not so high in our
country enough for randomized study. Furthermore, al-
though all consecutive cases of Onyx embolization for
dAVF were not treated by Scepter-assisted technique, it
was already a frontline technique for transarterial Onyx
embolization in our hospital because the preceding re-
sult of the technique had been very promising as previ-
ously reported [4]. Another limitation is that DSA was
not used for the first follow-up imaging in all cases,
which may miss a small slow-flow residual fistula. How-
ever, because the sensitivity of evaluating dAVF using
MRA source image was very high [4, 15] and no patient
showed recurrent symptom or recanalization on the
follow-up after complete occlusion, the durability of
Scepter-assisted technique may be reliable.
Conclusions
Scepter-assisted trans arterial Onyx embolization
showed a very high complete occlusion rate with a low
morbidity and no recurrence in aggressive type DAVF.
Scepter dual-lumen balloon catheter seems to be useful
tool for transarterial Onyx embolization of DAVF.
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